ENCODE biosample ENCBS754IVU

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: age

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens MTREX

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS754IVU: RNA-seq on K562 cells treated with a CRISPR gRNA against SETD1A. (SETD1A-BGKcLV33-50)


ENCODE biosample ENCBS754RPU

status: PUBLIC

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 81 year

tag: attribute

text: Homo sapiens female adult (81 years) with Cognitive impairment; middle frontal area 46 tissue

text: adult

characteristic: dev stage

characteristic: donor ID

text: Barbara Wold, Caltech

characteristic: lab

text: Homo sapiens

characteristic: organism

text: tissue

characteristic: sample type

text: female

characteristic: sex

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS754RPU: human_brain_Rush ID_E5448057_BS100_ENC4_cDNA677

characteristic: title


ENCODE biosample ENCBS754WGW

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: age

characteristic: cell line

text: Homo sapiens K562 cell line treated with 5 uM MB-3 for 4 hours, preserved by flash-freezing

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS754WGW: RNA-seq on human cell line K562

text: treatment_term_name: MB-3; treatment_type: chemical; duration: 4; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS755GCM

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

text: 36 year

text: Homo sapiens HL-60 cell line treated with 10 uM phorbol 13-acetate 12-myristate for 120 hours, 100 ng/mL interferon gamma for 24 hours, 100 ng/mL lipopolysaccharide for 24 hours

text: adult

text: acute promyelocytic leukemia

text: Ali Mortazavi, UCI

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS755GCM: HL-60 derived M1 macrophages (24hr)

text: treatment_term_id: CHEBI:37537; treatment_term_name: phorbol 13-acetate 12-myristate; treatment_type: chemical; duration: 120; duration_units: hour; treatment_term_id: UniProtKB:P01579; treatment_term_name: interferon gamma; treatment_type: protein; duration: 24; duration_units: hour; treatment_term_id: CHEBI:16412; treatment_term_name: lipopolysaccharide; treatment_type: chemical; duration: 24; duration_units: hour;


ENCODE biosample ENCBS756IEB

text: ENCODE

text: live

text: Generic

characteristic: SRA accession

text: 36 year

text: Homo sapiens HL-60 cell line treated with 10 uM phorbol 13-acetate 12-myristate for 120 hours, 10 ng/mL interleukin-13 for 12 hours, 10 ng/mL interleukin-4 for 12 hours

text: adult

characteristic: dev stage

characteristic: donor ID

text: acute promyelocytic leukemia

text: Ali Mortazavi, UCI

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS756IEB: HL-60 derived M2A macrophages (12hr)

text: treatment_term_id: CHEBI:37537; treatment_term_name: phorbol 13-acetate 12-myristate; treatment_type: chemical; duration: 120; duration_units: hour; treatment_term_id: UniProtKB:P35225; treatment_term_name: interleukin-13; treatment_type: protein; duration: 12; duration_units: hour; treatment_term_id: UniProtKB:P05112; treatment_term_name: interleukin-4; treatment_type: protein; duration: 12; duration_units: hour;


ENCODE biosample ENCBS757YGX

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

text: 30 year

characteristic: age

characteristic: cell line

text: Homo sapiens WTC11 cell line treated with 7.5 uM IWP-2 for 24 hours, 3 days post differentiation, preserved by flash-freezing

characteristic: description

text: adult

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: male

text: Coriell

text: ENCODE biosample ENCBS757YGX: iPSC differentiation in to cardiomycytes

characteristic: title

text: treatment_term_id: CHEBI:125649; treatment_term_name: IWP-2; treatment_type: chemical; duration: 24; duration_units: hour;


ENCODE biosample ENCBS757ZRT

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CWC15

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS757ZRT: RNA-seq on K562 cells treated with a CRISPR gRNA against CWC15. (CWC15-BGKcLV28-53)


ENCODE biosample ENCBS759VCT

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line treated with 10 nM Chaetocin for 12 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS759VCT: RNA-seq on human cell line K562

text: treatment_term_name: Chaetocin; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS759ZZR

text: ENCODE

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RNASEH2A

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS759ZZR: RNA-seq on K562 cells treated with a CRISPR gRNA against RNASEH2A. (RNASEH2A-BGKcLV30-37)


ENCODE biosample ENCBS761UUN

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

text: 30 year

characteristic: age

characteristic: cell line

text: Homo sapiens WTC11 cell line treated with 7.5 uM IWP-2 for 48 hours, 4 days post differentiation, preserved by flash-freezing

characteristic: description

text: adult

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: male

text: Coriell

text: ENCODE biosample ENCBS761UUN: iPSC differentiation in to cardiomycytes

characteristic: title

text: treatment_term_id: CHEBI:125649; treatment_term_name: IWP-2; treatment_type: chemical; duration: 48; duration_units: hour;


ENCODE biosample ENCBS762SPI

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens BRD4

text: adult

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

characteristic: source

text: ENCODE biosample ENCBS762SPI


ENCODE biosample ENCBS764AQQ

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens POLR2A

text: adult

characteristic: dev stage

characteristic: donor ID

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS764AQQ


ENCODE biosample ENCBS765CBQ

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SF3B2

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS765CBQ: RNA-seq on K562 cells treated with a CRISPR gRNA against SEPT11. (SEPT11-BGKcLV33-45)


ENCODE biosample ENCBS765SSW

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

text: 90 or above year

characteristic: age

text: Homo sapiens female adult (90 or above years) with Alzheimer's disease; middle frontal area 46 tissue

characteristic: description

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS765SSW: human_brain_Rush ID_E1302730_BS147_ENC4_cDNA697

characteristic: title


ENCODE biosample ENCBS765XDW

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 48 year

text: T-helper 17 cell

characteristic: cell type

text: Homo sapiens male adult (48 years) T-helper 17 primary cell

text: adult

text: John Stamatoyannopoulos, UW

text: Homo sapiens

text: primary cell

text: male

text: StemExpress

text: ENCODE biosample ENCBS765XDW


ENCODE biosample ENCBS768OOX

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 58 year

characteristic: cell line

text: Homo sapiens A549 cell line treated with 1 uM ZK216348 (agonist) for 4 hours

text: adult

characteristic: dev stage

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS768OOX

text: treatment_term_name: ZK216348; treatment_type: chemical; duration: 4; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS769NMQ

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens MED14 treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

characteristic: donor ID

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS769NMQ

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;


ENCODE biosample ENCBS769ODW

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CSDE1

characteristic: description

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS769ODW: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CSDE1. (CSDE1-BGHcLV29-42)

characteristic: title


ENCODE biosample ENCBS771BVR

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 82 year

text: Homo sapiens female adult (82 years) middle frontal area 46 tissue

text: adult

characteristic: dev stage

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS771BVR: human_brain_Rush ID_E5374703_BS155_ENC4_cDNA705


ENCODE biosample ENCBS771KWJ

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens DCPS

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS771KWJ: RNA-seq on K562 cells treated with a CRISPR gRNA against DCPS. (DCPS-BGKcLV28-64)


ENCODE biosample ENCBS773ARL

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CCNT1

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS773ARL: RNA-seq on K562 cells treated with a CRISPR gRNA against CCNT1. (CCNT1-BGKcLV26-65)


ENCODE biosample ENCBS773MQM

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

text: 58 year

characteristic: age

text: Homo sapiens A549 cell line treated with 1 uM Hydrocortisone (agonist) for 4 hours

characteristic: description

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS773MQM

characteristic: title

text: treatment_term_id: CHEBI:17650; treatment_term_name: Hydrocortisone; treatment_type: chemical; duration: 4; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS774XNI

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: 48 year

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens CDK7

text: adult

characteristic: dev stage

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

characteristic: source

text: ENCODE biosample ENCBS774XNI


ENCODE biosample ENCBS775FFI

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CCDC47

text: child

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS775FFI: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CCDC47. (CCDC47-BGHcLV27-45)


ENCODE biosample ENCBS777WED

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens POLR2A

text: adult

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS777WED


ENCODE biosample ENCBS777YEV

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line treated with 10 uM Crizotinib for 12 hours, preserved by flash-freezing

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS777YEV: RNA-seq on human cell line K562

characteristic: title

text: treatment_term_name: Crizotinib; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS781FVE

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 5 uM MB-3 for 24 hours, preserved by flash-freezing

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS781FVE: RNA-seq on human cell line K562

text: treatment_term_name: MB-3; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS783AAA

text: ENCODE

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

text: 53 year

text: Homo sapiens K562 cell line nucleolus fraction

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Thomas Gingeras, CSHL

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: Unknown Source

text: nucleolus

characteristic: subcellular fraction term name

text: ENCODE biosample ENCBS783AAA: leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC


ENCODE biosample ENCBS783LPC

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SEC31A

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS783LPC: RNA-seq on K562 cells treated with a CRISPR gRNA against SARNP. (SARNP-BGKcLV33-31)


ENCODE biosample ENCBS784AAA

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line nucleoplasmic fraction

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Thomas Gingeras, CSHL

text: Homo sapiens

text: cell line

text: female

text: Unknown Source

text: nucleoplasm

text: ENCODE biosample ENCBS784AAA: leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC

characteristic: title


ENCODE biosample ENCBS784CQN

text: ENCODE

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CDK9

text: child

characteristic: dev stage

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS784CQN: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CDK9. (CDK9-BGHcLV29-13)


ENCODE biosample ENCBS784DDT

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: John Lis, Cornell

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS784DDT


ENCODE biosample ENCBS785AAA

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line nuclear fraction

text: adult

text: chronic myelogenous leukemia (CML)

text: Thomas Gingeras, CSHL

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: Unknown Source

text: nucleus

characteristic: subcellular fraction term name

text: ENCODE biosample ENCBS785AAA: leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC


ENCODE biosample ENCBS785JFS

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SEPT11

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS785JFS: RNA-seq on K562 cells treated with a CRISPR gRNA against SEC62. (SEC62-BGKcLV33-40)

characteristic: title


ENCODE biosample ENCBS785JRJ

characteristic: External Id

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 30 year

characteristic: cell line

text: Homo sapiens WTC11 cell line, 5 days post differentiation, preserved by flash-freezing

text: adult

characteristic: dev stage

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: male

text: Coriell

characteristic: source

text: ENCODE biosample ENCBS785JRJ: iPSC differentiation in to cardiomycytes


ENCODE biosample ENCBS786AAA

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line polysomic fraction

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Thomas Gingeras, CSHL

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: Unknown Source

text: polysome

text: ENCODE biosample ENCBS786AAA: leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC


ENCODE biosample ENCBS786GUA

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Generic

text: 90 or above year

text: Homo sapiens male adult (90 or above years) with Alzheimer's disease; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

characteristic: sample type

text: male

characteristic: sex

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS786GUA: human_brain_Rush ID_E9972216_BS194_ENC4_cDNA748


ENCODE biosample ENCBS786TTZ

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RPS21

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS786TTZ: RNA-seq on K562 cells treated with a CRISPR gRNA against BMS1. (BMS1-BGKcLV33-4)

characteristic: title


ENCODE biosample ENCBS787ZKP

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with Alzheimer's disease; middle frontal area 46 tissue

text: adult

characteristic: dev stage

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

characteristic: source

text: middle frontal area 46

text: ENCODE biosample ENCBS787ZKP: human_brain_Rush ID_E5605087_BS124_ENC4_cDNA686


ENCODE biosample ENCBS791IIZ

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission package

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS791IIZ: Control CRISPR gRNA against no target in K562 cells followed by RNA-seq. (NT-BGKcLV26-2)


ENCODE biosample ENCBS792AAA

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: Homo sapiens GM12878 cell line cytosolic fraction

text: adult

text: Thomas Gingeras, CSHL

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: Coriell

text: cytosol

characteristic: subcellular fraction term name

text: ENCODE biosample ENCBS792AAA: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus


ENCODE biosample ENCBS793AAA

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: Homo sapiens GM12878 cell line nucleolus fraction

characteristic: description

text: adult

text: Thomas Gingeras, CSHL

text: Homo sapiens

text: cell line

text: female

text: Coriell

text: nucleolus

text: ENCODE biosample ENCBS793AAA: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus

characteristic: title


ENCODE biosample ENCBS793LRT

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SMG5

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS793LRT: RNA-seq on K562 cells treated with a CRISPR gRNA against SF3B2. (SF3B2-BGKcLV33-52)


ENCODE biosample ENCBS793NWJ

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission package

characteristic: cell line

text: Homo sapiens PC-9 cell line treated with 500 rad irradiation

characteristic: donor ID

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

text: not collected

text: Sigma

characteristic: source

text: ENCODE biosample ENCBS793NWJ

text: treatment_term_name: irradiation; treatment_type: irradiation;

characteristic: treatments


ENCODE biosample ENCBS794AAA

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: Homo sapiens GM12878 cell line nuclear fraction

text: adult

text: Thomas Gingeras, CSHL

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: Coriell

text: nucleus

characteristic: subcellular fraction term name

text: ENCODE biosample ENCBS794AAA: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus


ENCODE biosample ENCBS797LAW

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens RAD21 treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

characteristic: description

text: adult

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS797LAW

characteristic: title

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;


ENCODE biosample ENCBS797PYL

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 48 year

characteristic: age

characteristic: cell line

text: Homo sapiens OCI-LY7 cell line, subjected to a 6 hour pulse-chase

text: adult

characteristic: dev stage

text: B cell lymphoma

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

text: male

text: DSMZ

text: ENCODE biosample ENCBS797PYL


ENCODE biosample ENCBS797TJK

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line treated with 100 nM GSK J4 for 4 hours, preserved by flash-freezing

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS797TJK: RNA-seq on human cell line K562

text: treatment_term_name: GSK J4; treatment_type: chemical; duration: 4; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS798JQV

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 53 year

text: Homo sapiens K562 cell line treated with 5 uM JQ1 for 4 hours, preserved by flash-freezing

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS798JQV: RNA-seq on human cell line K562

text: treatment_term_name: JQ1; treatment_type: chemical; duration: 4; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS800REP

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: John Lis, Cornell

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS800REP

characteristic: title


ENCODE biosample ENCBS801JBH

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 90 or above year

characteristic: age

text: Homo sapiens female adult (90 or above years) with Alzheimer's disease; middle frontal area 46 tissue

text: adult

characteristic: dev stage

characteristic: donor ID

text: Barbara Wold, Caltech

characteristic: lab

text: Homo sapiens

text: tissue

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS801JBH: human_brain_Rush ID_E6264119_BS159_ENC4_cDNA709


ENCODE biosample ENCBS802NBR

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 48 year

characteristic: cell line

text: adult

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

text: Dr. Masato Kanemaki

characteristic: source

text: ENCODE biosample ENCBS802NBR

characteristic: treatments


ENCODE biosample ENCBS804NKI

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 78 year

text: Homo sapiens female adult (78 years) middle frontal area 46 tissue

characteristic: description

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

characteristic: sex

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS804NKI: human_brain_Rush ID_E6329379_BS157_ENC4_cDNA707


ENCODE biosample ENCBS805RWS

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: SRA accession

text: 36 year

characteristic: age

text: Homo sapiens HL-60 cell line treated with 10 uM phorbol 13-acetate 12-myristate for 120 hours, 10 ng/mL interleukin-13 for 72 hours, 10 ng/mL interleukin-4 for 72 hours

text: adult

characteristic: dev stage

characteristic: donor ID

text: acute promyelocytic leukemia

characteristic: health state

text: Ali Mortazavi, UCI

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS805RWS: HL-60 derived M2A macrophages (72hr)

characteristic: title

text: treatment_term_id: CHEBI:37537; treatment_term_name: phorbol 13-acetate 12-myristate; treatment_type: chemical; duration: 120; duration_units: hour; treatment_term_id: UniProtKB:P35225; treatment_term_name: interleukin-13; treatment_type: protein; duration: 72; duration_units: hour; treatment_term_id: UniProtKB:P05112; treatment_term_name: interleukin-4; treatment_type: protein; duration: 72; duration_units: hour;


ENCODE biosample ENCBS805VQZ

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens METTL1

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS805VQZ: RNA-seq on HepG2 cells treated with a CRISPR gRNA against METTL1. (METTL1-BGHcLV24-38)


ENCODE biosample ENCBS806IYJ

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 25 year

text: Homo sapiens Calu3 cell line

text: adult

text: Lung adenocarcinoma

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS806IYJ


ENCODE biosample ENCBS807YLY

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 36 year

text: Homo sapiens HL-60 cell line treated with 10 uM phorbol 13-acetate 12-myristate for 120 hours, 100 ng/mL interferon gamma for 72 hours, 100 ng/mL lipopolysaccharide for 72 hours

characteristic: description

text: adult

text: acute promyelocytic leukemia

text: Ali Mortazavi, UCI

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS807YLY: HL-60 derived M1 macrophages (72hr)

text: treatment_term_id: CHEBI:37537; treatment_term_name: phorbol 13-acetate 12-myristate; treatment_type: chemical; duration: 120; duration_units: hour; treatment_term_id: UniProtKB:P01579; treatment_term_name: interferon gamma; treatment_type: protein; duration: 72; duration_units: hour; treatment_term_id: CHEBI:16412; treatment_term_name: lipopolysaccharide; treatment_type: chemical; duration: 72; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS811ACC

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens DBNL

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS811ACC: RNA-seq on HepG2 cells treated with a CRISPR gRNA against DBNL. (DBNL-BGHcLV29-59)

characteristic: title


ENCODE biosample ENCBS811FZJ

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

text: live

text: Generic

text: 30 year

characteristic: cell line

text: Homo sapiens WTC11 cell line treated with 7.5 uM IWP-2 for 48 hours, 4 days post differentiation, preserved by flash-freezing

text: adult

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

text: Coriell

text: ENCODE biosample ENCBS811FZJ: iPSC differentiation in to cardiomycytes

text: treatment_term_id: CHEBI:125649; treatment_term_name: IWP-2; treatment_type: chemical; duration: 48; duration_units: hour;


ENCODE biosample ENCBS811YQF

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens API5

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS811YQF: RNA-seq on K562 cells treated with a CRISPR gRNA against API5. (API5-BGKcLV26-28)


ENCODE biosample ENCBS812VEL

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line treated with 10 uM Crizotinib for 12 hours, preserved by flash-freezing

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS812VEL: RNA-seq on human cell line K562

text: treatment_term_name: Crizotinib; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS813CQS

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

text: live

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ARHGEF2

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS813CQS: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ARHGEF2. (ARHGEF2-BGHcLV29-3)

characteristic: title


ENCODE biosample ENCBS813IWN

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RNPC3

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS813IWN: RNA-seq on K562 cells treated with a CRISPR gRNA against RNPC3. (RNPC3-BGKcLV30-42)


ENCODE biosample ENCBS816PFE

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line treated with 7.5 nM Panobinostat for 24 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS816PFE: RNA-seq on human cell line K562

text: treatment_term_name: Panobinostat; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS816PZZ

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

text: live

text: Generic

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens BRD2

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS816PZZ: RNA-seq on K562 cells treated with a CRISPR gRNA against BRD2. (BRD2-BGKcLV26-42)


ENCODE biosample ENCBS817RRI

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 30 year

text: Homo sapiens WTC11 cell line, 6 days post differentiation, preserved by flash-freezing

text: adult

characteristic: dev stage

characteristic: donor ID

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: male

text: Coriell

text: ENCODE biosample ENCBS817RRI: iPSC differentiation in to cardiomycytes

characteristic: title


ENCODE biosample ENCBS819GGD

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

text: 77 year

text: Homo sapiens female adult (77 years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

characteristic: lab

text: Homo sapiens

characteristic: organism

text: tissue

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS819GGD: human_brain_Rush ID_E6018011_BS156_ENC4_cDNA706


ENCODE biosample ENCBS819UHF

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 90 or above year

text: Homo sapiens female adult (90 or above years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: female

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS819UHF: human_brain_Rush ID_4163791_BS115_ENC4_cDNA665


ENCODE biosample ENCBS820TRC

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SECISBP2

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS820TRC: RNA-seq on K562 cells treated with a CRISPR gRNA against SEC31A. (SEC31A-BGKcLV33-37)


ENCODE biosample ENCBS822FZF

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ATP5F1A

characteristic: description

text: child

characteristic: dev stage

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS822FZF: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ATP5A1. (ATP5A1-BGHcLV29-9)


ENCODE biosample ENCBS823LFQ

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

text: Homo sapiens PC-9 cell line, subjected to a 2 hour pulse-chase

characteristic: donor ID

text: Mats Ljungman, UMichigan

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: not collected

text: Sigma

text: ENCODE biosample ENCBS823LFQ

characteristic: title


ENCODE biosample ENCBS824XKV

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RBM25

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS824XKV: RNA-seq on K562 cells treated with a CRISPR gRNA against RBM25. (RBM25-BGKcLV30-12)


ENCODE biosample ENCBS825COF

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 25 uM Galeterone for 12 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS825COF: RNA-seq on human cell line K562

text: treatment_term_name: Galeterone; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS825TMJ

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

text: 30 year

characteristic: age

text: Homo sapiens WTC11 cell line, preserved by flash-freezing

characteristic: description

text: adult

characteristic: dev stage

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: Coriell

text: ENCODE biosample ENCBS825TMJ: iPSC


ENCODE biosample ENCBS826WOF

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Generic

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens CTCF

text: adult

characteristic: donor ID

text: colorectal carcinoma

text: Erez Aiden, Baylor

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS826WOF

characteristic: title


ENCODE biosample ENCBS828KDP

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM AZD2906 (agonist) for 4 hours

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS828KDP

text: treatment_term_name: AZD2906; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS829GTX

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 1% DMSO for 4 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS829GTX: RNA-seq on human cell line K562

text: treatment_term_name: DMSO; treatment_type: chemical; duration: 4; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS833CJR

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Generic

text: 90 or above year

characteristic: age

text: Homo sapiens female adult (90 or above years) middle frontal area 46 tissue

characteristic: description

text: adult

characteristic: dev stage

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

characteristic: sex

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS833CJR: human_brain_Rush ID_3002106_BS114_ENC4_cDNA664


ENCODE biosample ENCBS833WEY

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 47 year

text: motor neuron

characteristic: cell type

text: Homo sapiens male adult (47 years) motor neuron in vitro differentiated cells, preserved by flash-freezing

text: adult

characteristic: donor ID

text: Donor with Amyotrophic Lateral Sclerosis

text: Michael Snyder, Stanford

characteristic: lab

text: Homo sapiens

characteristic: organism

text: in vitro differentiated cells

text: male

text: Cooper-Knock lab, University of Sheffield, UK

text: ENCODE biosample ENCBS833WEY: RNA-seq on human

characteristic: title


ENCODE biosample ENCBS834CIE

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 36 year

text: MCF 10A

characteristic: cell line

text: Homo sapiens MCF 10A cell line

text: adult

text: fibrocystic disease

characteristic: health state

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS834CIE


ENCODE biosample ENCBS835XBG

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Generic

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR

characteristic: description

text: child

characteristic: dev stage

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS835XBG: Control CRISPR gRNA against no target in HepG2 cells followed by RNA-seq. (NT-BGHcLV24-2)


ENCODE biosample ENCBS838SCE

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: endothelial cell of umbilical vein

characteristic: cell type

text: Homo sapiens male newborn endothelial of umbilical vein primary cell, subjected to a 2 hour pulse-chase

text: newborn

characteristic: donor ID

text: Mats Ljungman, UMichigan

characteristic: lab

text: Homo sapiens

text: primary cell

text: male

text: Lonza

text: ENCODE biosample ENCBS838SCE


ENCODE biosample ENCBS839OMR

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 87 year

text: Homo sapiens female adult (87 years) with Alzheimer's disease, Cognitive impairment; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS839OMR: human_brain_Rush ID_2585111_BS94_ENC4_cDNA671

characteristic: title


ENCODE biosample ENCBS839YIC

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Generic

text: 15 year

characteristic: age

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens DBNL

text: child

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS839YIC: RNA-seq on HepG2 cells treated with a CRISPR gRNA against DBNL. (DBNL-BGHcLV29-60)


ENCODE biosample ENCBS840KHA

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SEPT7

characteristic: description

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS840KHA: RNA-seq on K562 cells treated with a CRISPR gRNA against SEC63. (SEC63-BGKcLV33-41)


ENCODE biosample ENCBS841DKK

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RUVBL2

text: child

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS841DKK: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RUVBL2. (RUVBL2-BGHcLV31-21)


ENCODE biosample ENCBS841VVB

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Generic

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ARHGEF1

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS841VVB: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ARHGEF1. (ARHGEF1-BGHcLV27-13)

characteristic: title


ENCODE biosample ENCBS841YGY

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 15 year

characteristic: cell line

text: Homo sapiens A673 cell line

text: child

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS841YGY


ENCODE biosample ENCBS842EEJ

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 25 year

text: Homo sapiens Calu3 cell line

characteristic: description

text: adult

characteristic: dev stage

text: Lung adenocarcinoma

characteristic: health state

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS842EEJ


ENCODE biosample ENCBS842HKQ

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens BYSL

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS842HKQ: RNA-seq on K562 cells treated with a CRISPR gRNA against BYSL. (BYSL-BGKcLV26-43)


ENCODE biosample ENCBS842VIG

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Generic

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CARHSP1

text: child

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS842VIG: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CARHSP1. (CARHSP1-BGHcLV27-37)


ENCODE biosample ENCBS844MEQ

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens DCP1A

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS844MEQ: RNA-seq on K562 cells treated with a CRISPR gRNA against DCP1A. (DCP1A-BGKcLV28-62)

characteristic: title


ENCODE biosample ENCBS848YJL

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 36 year

text: Homo sapiens HL-60 cell line treated with 10 uM phorbol 13-acetate 12-myristate for 120 hours

characteristic: description

text: adult

characteristic: dev stage

text: acute promyelocytic leukemia

text: Ali Mortazavi, UCI

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS848YJL: HL-60 derived M0 macrophages

text: treatment_term_id: CHEBI:37537; treatment_term_name: phorbol 13-acetate 12-myristate; treatment_type: chemical; duration: 120; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS849QLO

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line treated with 25 uM Galeterone for 4 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS849QLO: RNA-seq on human cell line K562

text: treatment_term_name: Galeterone; treatment_type: chemical; duration: 4; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS850LSL

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC secondary accession

text: live

text: Generic

text: 58 year

characteristic: age

text: Homo sapiens A549 cell line treated with 1 uM dexamethasone (agonist) for 4 hours

text: adult

characteristic: donor ID

text: Tim Reddy, Duke

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS850LSL

text: treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS851OMB

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with mild cognitive impairment; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

characteristic: sample type

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS851OMB: human_brain_Rush ID_E3486019_BS181_ENC4_cDNA735

characteristic: title


ENCODE biosample ENCBS851OSG

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

text: 48 year

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens RAD21

characteristic: description

text: adult

characteristic: dev stage

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

characteristic: source

text: ENCODE biosample ENCBS851OSG


ENCODE biosample ENCBS852NWS

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens DDX23

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS852NWS: RNA-seq on K562 cells treated with a CRISPR gRNA against DDX23. (DDX23-BGKcLV28-74)


ENCODE biosample ENCBS853HUJ

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CDK9

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS853HUJ: RNA-seq on K562 cells treated with a CRISPR gRNA against CDK9. (CDK9-BGKcLV28-14)


ENCODE biosample ENCBS853KVF

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line

text: adult

text: chronic myelogenous leukemia (CML)

text: John Lis, Cornell

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS853KVF

characteristic: title


ENCODE biosample ENCBS853VCN

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 63 year

text: Homo sapiens male adult (63 years) heart left ventricle tissue, preserved by flash-freezing

characteristic: description

text: adult

characteristic: dev stage

text: sarcoid (EF 23%, LVEDD 5.7, LVPWd: 0.68)

text: Michael Snyder, Stanford

text: Homo sapiens

text: tissue

text: male

text: Shin Lin

characteristic: source

text: heart left ventricle

characteristic: tissue

text: ENCODE biosample ENCBS853VCN: Homo sapiens heart left ventricle tissue


ENCODE biosample ENCBS854FIQ

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens AIMP1

text: child

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS854FIQ: RNA-seq on HepG2 cells treated with a CRISPR gRNA against AIMP1. (AIMP1-BGHcLV27-3)


ENCODE biosample ENCBS854SIX

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 58 year

characteristic: age

text: adult

characteristic: donor ID

text: Tim Reddy, Duke

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS854SIX

characteristic: treatments


ENCODE biosample ENCBS857TTQ

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

text: live

text: Generic

text: 19 year

text: mammary epithelial cell

characteristic: cell type

text: Homo sapiens female adult (19 years) mammary epithelial primary cell, subjected to a 6 hour pulse-chase

characteristic: description

text: adult

text: Mats Ljungman, UMichigan

text: Homo sapiens

characteristic: organism

text: primary cell

characteristic: sample type

text: female

text: Lonza

text: ENCODE biosample ENCBS857TTQ

characteristic: title


ENCODE biosample ENCBS857ZTZ

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 48 year

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens SMARCA5

text: adult

characteristic: dev stage

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

characteristic: source

text: ENCODE biosample ENCBS857ZTZ


ENCODE biosample ENCBS858AAA

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line cytosolic fraction

text: child

characteristic: donor ID

text: hepatocellular carcinoma

text: Thomas Gingeras, CSHL

characteristic: lab

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: cytosol

characteristic: subcellular fraction term name

text: ENCODE biosample ENCBS858AAA: hepatocellular carcinoma


ENCODE biosample ENCBS858EAQ

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 48 year

characteristic: description

text: adult

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS858EAQ


ENCODE biosample ENCBS859AAA

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line nucleolus fraction

text: child

text: hepatocellular carcinoma

text: Thomas Gingeras, CSHL

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: ATCC

text: nucleolus

text: ENCODE biosample ENCBS859AAA: hepatocellular carcinoma

characteristic: title


ENCODE biosample ENCBS859OJC

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens DBNL

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS859OJC: RNA-seq on K562 cells treated with a CRISPR gRNA against DBNL. (DBNL-BGKcLV28-59)


ENCODE biosample ENCBS860AAA

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line nuclear fraction

text: child

characteristic: donor ID

text: hepatocellular carcinoma

text: Thomas Gingeras, CSHL

characteristic: lab

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: nucleus

characteristic: subcellular fraction term name

text: ENCODE biosample ENCBS860AAA: hepatocellular carcinoma


ENCODE biosample ENCBS862EQG

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RIOK1

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS862EQG: RNA-seq on K562 cells treated with a CRISPR gRNA against RIOK1. (RIOK1-BGKcLV30-34)


ENCODE biosample ENCBS862OGM

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CPSF2

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS862OGM: RNA-seq on K562 cells treated with a CRISPR gRNA against CPSF2. (CPSF2-BGKcLV28-33)

characteristic: title


ENCODE biosample ENCBS863SFU

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: SRA accession

text: 36 year

characteristic: age

text: MCF 10A

text: Homo sapiens MCF 10A cell line

text: adult

characteristic: dev stage

text: fibrocystic disease

characteristic: health state

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS863SFU


ENCODE biosample ENCBS867AQR

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens AIMP1

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS867AQR: RNA-seq on K562 cells treated with a CRISPR gRNA against AIMP1. (AIMP1-BGKcLV26-20)


ENCODE biosample ENCBS869GJQ

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 48 year

text: Homo sapiens OCI-LY7 cell line

characteristic: description

text: adult

text: B cell lymphoma

text: Mats Ljungman, UMichigan

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: DSMZ

text: ENCODE biosample ENCBS869GJQ


ENCODE biosample ENCBS869SJL

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 30 year

characteristic: cell line

text: Homo sapiens WTC11 cell line

text: adult

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: Coriell

text: ENCODE biosample ENCBS869SJL

characteristic: title


ENCODE biosample ENCBS870MVU

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: SRA accession

text: 82 year

characteristic: age

text: Homo sapiens male adult (82 years) middle frontal area 46 tissue

text: adult

characteristic: dev stage

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: male

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS870MVU: human_brain_Rush ID_E1554367_BS148_ENC4_cDNA698


ENCODE biosample ENCBS870SOW

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CARS

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS870SOW: RNA-seq on K562 cells treated with a CRISPR gRNA against CARS. (CARS-BGKcLV26-58)


ENCODE biosample ENCBS873CAZ

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RBM25

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS873CAZ: RNA-seq on K562 cells treated with a CRISPR gRNA against RBM25. (RBM25-BGKcLV30-11)


ENCODE biosample ENCBS875BBD

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 86 year

text: Homo sapiens female adult (86 years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: female

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS875BBD: human_brain_Rush ID_E1121653_BS119_ENC4_cDNA681

characteristic: title


ENCODE biosample ENCBS875FPP

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: SRA accession

text: 15 year

characteristic: age

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CPSF3

text: child

characteristic: dev stage

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS875FPP: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CPSF3. (CPSF3-BGHcLV29-35)


ENCODE biosample ENCBS876JPT

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens CDK7

text: adult

characteristic: donor ID

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

characteristic: source

text: ENCODE biosample ENCBS876JPT


ENCODE biosample ENCBS876WAS

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RBM25

characteristic: description

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS876WAS: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RBM25. (RBM25-BGHcLV32-10)


ENCODE biosample ENCBS876ZME

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 90 or above year

text: Homo sapiens male adult (90 or above years) with Alzheimer's disease; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: male

characteristic: sex

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS876ZME: human_brain_Rush ID_E8243181_BS167_ENC4_cDNA717


ENCODE biosample ENCBS881DDA

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: SRA accession

text: 50 year

characteristic: age

text: naive thymus-derived CD4-positive, alpha-beta T cell

characteristic: cell type

text: Homo sapiens male adult (50 years) naive thymus-derived CD4-positive, alpha-beta T primary cell

text: adult

characteristic: dev stage

text: John Stamatoyannopoulos, UW

text: Homo sapiens

text: primary cell

text: male

text: StemExpress

text: ENCODE biosample ENCBS881DDA

characteristic: title


ENCODE biosample ENCBS881VLN

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 50 uM C646 for 48 hours, preserved by flash-freezing

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS881VLN: RNA-seq on human cell line K562

text: treatment_term_name: C646; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS881WRE

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line treated with 10 nM Chaetocin for 24 hours, preserved by flash-freezing

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS881WRE: RNA-seq on human cell line K562

text: treatment_term_name: Chaetocin; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS885BFB

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: SRA accession

text: 90 or above year

characteristic: age

text: Homo sapiens female adult (90 or above years) with Alzheimer's disease; middle frontal area 46 tissue

text: adult

characteristic: dev stage

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

characteristic: sex

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS885BFB: human_brain_Rush ID_E1005516_BS117_ENC4_cDNA679

characteristic: title


ENCODE biosample ENCBS885CJQ

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SRA1

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS885CJQ: RNA-seq on K562 cells treated with a CRISPR gRNA against SRA1. (SRA1-BGKcLV33-74)


ENCODE biosample ENCBS885LGM

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SPATS2L

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS885LGM: RNA-seq on K562 cells treated with a CRISPR gRNA against SPAG9. (SPAG9-BGKcLV33-67)


ENCODE biosample ENCBS887OHV

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: SRA accession

text: 36 year

characteristic: age

text: Homo sapiens HL-60 cell line treated with 10 uM phorbol 13-acetate 12-myristate for 120 hours, 100 ng/mL lipopolysaccharide for 12 hours, 100 ng/mL interferon gamma for 12 hours

text: adult

characteristic: dev stage

text: acute promyelocytic leukemia

text: Ali Mortazavi, UCI

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS887OHV: HL-60 derived M1 macrophages (12hr)

text: treatment_term_id: CHEBI:37537; treatment_term_name: phorbol 13-acetate 12-myristate; treatment_type: chemical; duration: 120; duration_units: hour; treatment_term_id: CHEBI:16412; treatment_term_name: lipopolysaccharide; treatment_type: chemical; duration: 12; duration_units: hour; treatment_term_id: UniProtKB:P01579; treatment_term_name: interferon gamma; treatment_type: protein; duration: 12; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS887WYP

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ACTN4

text: child

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS887WYP: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ACTN4. (ACTN4-BGHcLV25-6)

characteristic: title


ENCODE biosample ENCBS890OMC

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 55 year

text: motor neuron

characteristic: cell type

text: Homo sapiens male adult (55 years) motor neuron in vitro differentiated cells, preserved by flash-freezing

text: adult

text: Healthy donor

characteristic: health state

text: Michael Snyder, Stanford

characteristic: lab

text: Homo sapiens

text: in vitro differentiated cells

text: male

text: Cooper-Knock lab, University of Sheffield, UK

characteristic: source

text: ENCODE biosample ENCBS890OMC: RNA-seq on human


ENCODE biosample ENCBS896CZM

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line treated with 100 nM GSK J4 for 48 hours, preserved by flash-freezing

characteristic: description

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS896CZM: RNA-seq on human cell line K562

text: treatment_term_name: GSK J4; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS896MIR

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ADAT1

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS896MIR: RNA-seq on K562 cells treated with a CRISPR gRNA against ADAT1. (ADAT1-BGKcLV26-7)


ENCODE biosample ENCBS897FOF

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CAPRIN1

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS897FOF: RNA-seq on K562 cells treated with a CRISPR gRNA against CAPRIN1. (CAPRIN1-BGKcLV26-54)

characteristic: title


ENCODE biosample ENCBS897RMB

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission model

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens REXO2

text: child

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS897RMB: RNA-seq on HepG2 cells treated with a CRISPR gRNA against REXO2. (REXO2-BGHcLV32-30)


ENCODE biosample ENCBS898EKF

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 90 or above year

characteristic: age

text: Homo sapiens female adult (90 or above years) with mild cognitive impairment; middle frontal area 46 tissue

characteristic: description

text: adult

characteristic: dev stage

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS898EKF: human_brain_Rush ID_E1805112_BS175_ENC4_cDNA729


ENCODE biosample ENCBS898HTY

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens AHCYL2

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS898HTY: RNA-seq on K562 cells treated with a CRISPR gRNA against AHCYL2. (AHCYL2-BGKcLV26-17)


ENCODE biosample ENCBS903KZP

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

text: 53 year

text: Homo sapiens female adult (53 years) right atrium auricular region tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

characteristic: sex

text: Kristin Ardlie

text: right atrium auricular region

text: ENCODE biosample ENCBS903KZP: Heart - Atrial Appendage

characteristic: title


ENCODE biosample ENCBS904CGT

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 90 or above year

text: Homo sapiens female adult (90 or above years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

characteristic: lab

text: Homo sapiens

text: tissue

text: female

text: Rush University

characteristic: source

text: middle frontal area 46

text: ENCODE biosample ENCBS904CGT: human_brain_Rush ID_E7469794_BS126_ENC4_cDNA688


ENCODE biosample ENCBS904RVQ

text: ENCODE

text: live

text: Generic

characteristic: SRA accession

text: 48 year

characteristic: age

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens MED14

characteristic: description

text: adult

characteristic: dev stage

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS904RVQ


ENCODE biosample ENCBS904ZTD

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens APEH

text: child

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS904ZTD: RNA-seq on HepG2 cells treated with a CRISPR gRNA against APEH. (APEH-BGHcLV27-9)


ENCODE biosample ENCBS907ALU

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CHCHD3

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS907ALU: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CHCHD3. (CHCHD3-BGHcLV29-18)


ENCODE biosample ENCBS907MRZ

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS907MRZ: Control CRISPR gRNA against no target in HepG2 cells followed by RNA-seq. (NT-BGHcLV32-1)

characteristic: title


ENCODE biosample ENCBS909SFC

text: ENCODE

text: live

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CTTN

characteristic: description

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS909SFC: RNA-seq on K562 cells treated with a CRISPR gRNA against CTTN. (CTTN-BGKcLV28-52)


ENCODE biosample ENCBS909TQU

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 55 year

text: motor neuron

characteristic: cell type

text: Homo sapiens male adult (55 years) motor neuron in vitro differentiated cells, preserved by flash-freezing

text: adult

characteristic: donor ID

text: Healthy donor

characteristic: health state

text: Michael Snyder, Stanford

text: Homo sapiens

text: in vitro differentiated cells

text: male

text: Cooper-Knock lab, University of Sheffield, UK

text: ENCODE biosample ENCBS909TQU: RNA-seq on human


ENCODE biosample ENCBS910GVI

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CDV3

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS910GVI: RNA-seq on K562 cells treated with a CRISPR gRNA against CDV3. (CDV3-BGKcLV28-16)


ENCODE biosample ENCBS911GLO

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line treated with 25 uM Galeterone for 12 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS911GLO: RNA-seq on human cell line K562

characteristic: title

text: treatment_term_name: Galeterone; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS911ZFS

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

characteristic: SRA accession

text: 58 year

characteristic: age

text: Homo sapiens A549 cell line treated with 1 uM RU486 (agonist) for 4 hours

characteristic: description

text: adult

characteristic: dev stage

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS911ZFS

text: treatment_term_id: CHEBI:50692; treatment_term_name: RU486; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS914ACI

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

text: 90 or above year

text: Homo sapiens female adult (90 or above years) middle frontal area 46 tissue

text: adult

characteristic: donor ID

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS914ACI: human_brain_Rush ID_E7461192_BS125_ENC4_cDNA687


ENCODE biosample ENCBS914PTZ

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ADD3

text: child

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS914PTZ: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ADD3. (ADD3-BGHcLV25-13)


ENCODE biosample ENCBS915DVB

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS915DVB: Control CRISPR gRNA against no target in K562 cells followed by RNA-seq. (NT-BGKcLV30-1)

characteristic: title


ENCODE biosample ENCBS916HYF

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CARS

characteristic: description

text: child

characteristic: dev stage

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS916HYF: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CARS. (CARS-BGHcLV27-39)


ENCODE biosample ENCBS916PZF

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR

text: child

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS916PZF: Control CRISPR gRNA against no target in HepG2 cells followed by RNA-seq. (NT-BGHcLV25-1)


ENCODE biosample ENCBS916YIG

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RRP8

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS916YIG: RNA-seq on K562 cells treated with a CRISPR gRNA against RPS21. (RPS21-BGKcLV33-11)


ENCODE biosample ENCBS917FHP

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: SRA accession

text: 35 year

text: naive thymus-derived CD4-positive, alpha-beta T cell

characteristic: cell type

text: Homo sapiens male adult (35 years) naive thymus-derived CD4-positive, alpha-beta T primary cell

text: adult

text: Yijun Ruan, JAX

characteristic: lab

text: Homo sapiens

text: primary cell

text: male

characteristic: sex

text: AllCells

text: ENCODE biosample ENCBS917FHP

characteristic: title